Consolidated Statements of Changes in Equity - CAD ($) $ in Millions |
Total |
Issued capital [member]
Preferred shares and other equity instruments [member]
|
Issued capital [member]
Common shares [member]
|
Treasury instruments [member]
Preferred shares and other equity instruments [member]
|
Treasury instruments [member]
Common shares [member]
|
Retained earnings [member] |
Other components of equity [member] |
Equity attributable to shareholders [member] |
Non-controlling interests [member] |
FVOCI securities and loans [member]
Other components of equity [member]
|
Foreign currency translation reserve [member]
Other components of equity [member]
|
Cash flow hedge reserve [member]
Other components of equity [member]
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of period (Previously stated [member]) at Oct. 31, 2022 | $ 108,175 | $ 7,323 | $ 17,318 | $ (5) | $ (334) | $ 78,037 | $ 5,725 | $ 108,064 | $ 111 | $ (2,357) | $ 5,688 | $ 2,394 |
| Balance at beginning of period (Transition adjustment [member]) at Oct. 31, 2022 | (2,359) | (2,359) | (2,359) | |||||||||
| Balance at beginning of period (Currently Restated [member]) at Oct. 31, 2022 | 105,816 | 7,323 | 17,318 | (5) | (334) | 75,678 | 5,725 | 105,705 | 111 | (2,357) | 5,688 | 2,394 |
| Balance at beginning of period at Oct. 31, 2022 | 17,318 | (5) | (334) | |||||||||
| Changes in equity | ||||||||||||
| Issues of share capital and other equity instruments | 2,081 | 2,080 | 1 | 2,081 | ||||||||
| Sales of treasury shares and other equity instruments | 4,174 | 515 | 3,659 | 4,174 | ||||||||
| Purchases of treasury shares and other equity instruments | (4,075) | (519) | (3,556) | (4,075) | ||||||||
| Share-based compensation awards | 4 | 4 | 4 | |||||||||
| Dividends on common shares | (7,443) | (7,443) | (7,443) | |||||||||
| Dividends on preferred shares and distributions on other equity instruments | (257) | (236) | (236) | (21) | ||||||||
| Other | (18) | (18) | (18) | |||||||||
| Net income | 14,612 | 14,605 | 14,605 | 7 | ||||||||
| Total other comprehensive income (loss), net of taxes | 253 | (876) | 1,127 | 251 | 2 | (159) | 924 | 362 | ||||
| Balance at end of period (Previously stated [member]) at Oct. 31, 2023 | 115,147 | 7,323 | 19,398 | (9) | (231) | 81,715 | 6,852 | 115,048 | 99 | (2,516) | 6,612 | 2,756 |
| Balance at end of period (Transition adjustment [member]) at Oct. 31, 2023 | (656) | 656 | 656 | |||||||||
| Balance at end of period (Currently Restated [member]) at Oct. 31, 2023 | 115,147 | 7,323 | 19,398 | (9) | (231) | 81,059 | 7,508 | 115,048 | 99 | (1,860) | 6,612 | 2,756 |
| Balance at end of period at Oct. 31, 2023 | 115,147 | 7,323 | 19,398 | (9) | (231) | 81,715 | 6,852 | 115,048 | 99 | (2,516) | 6,612 | 2,756 |
| Changes in equity | ||||||||||||
| Issues of share capital and other equity instruments | 4,330 | 2,720 | 1,628 | (18) | 4,330 | |||||||
| Common shares purchased for cancellation | (140) | (13) | (127) | (140) | ||||||||
| Redemption of preferred shares and other equity instruments | (1,021) | (1,023) | 2 | (1,021) | ||||||||
| Sales of treasury shares and other equity instruments | 6,717 | 1,245 | 5,472 | 6,717 | ||||||||
| Purchases of treasury shares and other equity instruments | (6,527) | (1,225) | (5,302) | (6,527) | ||||||||
| Share-based compensation awards | 69 | 69 | 69 | |||||||||
| Dividends on common shares | (7,916) | (7,916) | (7,916) | |||||||||
| Dividends on preferred shares and distributions on other equity instruments | (328) | (322) | (322) | (6) | ||||||||
| Other | 24 | 24 | 24 | |||||||||
| Net income | 16,240 | 16,230 | 16,230 | 10 | ||||||||
| Total other comprehensive income (loss), net of taxes | 597 | (393) | 990 | 597 | 963 | 516 | (489) | |||||
| Balance at end of period at Oct. 31, 2024 | $ 127,192 | $ 9,020 | $ 21,013 | $ 11 | $ (61) | $ 88,608 | $ 8,498 | $ 127,089 | $ 103 | $ (897) | $ 7,128 | $ 2,267 |